Aa
A
A
Close
1569985 tn?1328251082
FDA Alert for Cardiac drug
New FDA Medwatch Alert
Sent to subscribers of: olmesartan systemic, olmesartan
Drug Safety Communication: Olmesartan Medoxomil - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
July 3, 2013
Audience: Health Professional, Cardiology, Patient.
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan. Read more.
More FDA Medwatch Alerts...
Cancel
0 Answers
Page 1 of 1
Your Answer
Avatar universal
Answer
Do you know how to answer? Tap here to leave your answer...
Answer
Answer
Post Answer
A
A
Doctor Ratings & Reviews
Who are the top-rated Cardiologists in your area?
Heart Rhythm Community Resources
Top Arrhythmias Answerers
1807132 tn?1318747197
Blank
Chicago, IL
1423357 tn?1511089042
Blank
Central, MA
Avatar universal
Blank
Avatar universal
Blank
12492606 tn?1459877633
Blank